Table 2.
Differentially accumulated carbohydrates, amino acids, organic acids and vitamins compounds with VIP (variable importance in projection) ≥ 1, and fold change ≥1.6 and ≤ 0.6 as for as for upregulation/downregulation in the cv. ‘Zibao’ CK and BF
| Component name | Metabolite name | Average content | Fold change (BF vs. CK) |
VIP | Type | |
|---|---|---|---|---|---|---|
| CK | BF | |||||
| Carbohydrates | D(−)-Threose | 5.60E+ 03 | 8.46E+ 03 | 3.70E+ 00 | 1.03E+ 00 | up |
| Amino acid and derivatives | L-Tyramine | 2.01E+ 05 | 7.84E+ 05 | 3.90E+ 00 | 1.40E+ 00 | up |
| N-γ-Acetyl-N-2-Formyl-5-methoxykynurenamine | 2.63E+ 05 | 4.23E+ 05 | 1.61E+ 00 | 1.47E+ 00 | up | |
| L-Aspartic acid | 1.19E+ 07 | 7.10E+ 06 | 5.98E-01 | 1.07E+ 00 | down | |
| CYS-GLY | 5.61E+ 04 | 3.25E+ 04 | 5.79E-01 | 1.49E+ 00 | down | |
| L-Homocystine | 2.09E+ 05 | 1.19E+ 05 | 5.72E-01 | 1.28E+ 00 | down | |
| Phenylacetyl-L-glutamine | 1.61E+ 05 | 9.01E+ 04 | 5.61E-01 | 1.06E+ 00 | down | |
| Aspartic acid | 1.05E+ 07 | 5.83E+ 06 | 5.55E-01 | 1.15E+ 00 | down | |
| Organic acids and derivatives | α-Hydroxyisobutyric acid | 1.80E+ 05 | 8.28E+ 05 | 4.61E+ 00 | 1.37E+ 00 | up |
| (S)-(−)-2-Hydroxyisocaproic acid | 2.59E+ 04 | 7.88E+ 04 | 3.05E+ 00 | 1.15E+ 00 | up | |
| Isochlorogenic acid B | 7.36E+ 04 | 1.68E+ 05 | 2.28E+ 00 | 1.37E+ 00 | up | |
| Chlorogenic acid methyl ester | 2.26E+ 04 | 4.39E+ 04 | 1.94E+ 00 | 1.14E+ 00 | up | |
| 2,3-Dihydroxybenzoic acid | 9.30E+ 05 | 1.74E+ 06 | 1.87E+ 00 | 1.41E+ 00 | up | |
| 2-Hydroxybutanoic acid | 3.35E+ 04 | 5.67E+ 04 | 1.69E+ 00 | 1.48E+ 00 | up | |
| D-Pantothenic dcid | 1.39E+ 04 | 2.35E+ 04 | 1.69E+ 00 | 1.19E+ 00 | up | |
| Phosphoenolpyruvate trisodium salt | 7.34E+ 04 | 4.08E+ 04 | 5.56E-01 | 1.46E+ 00 | down | |
| Vitamins and derivatives | delta-Tocopherol | 2.68E+ 03 | 9.71E+ 03 | 3.62E+ 00 | 1.48E+ 00 | up |
| Thiamine pyrophosphate | 8.41E+ 03 | 1.44E+ 04 | 1.71E+ 00 | 1.46E+ 00 | up | |
| Orotic acid | 1.52E+ 05 | 2.59E+ 05 | 1.71E+ 00 | 1.57E+ 00 | up | |